Lidocaine Hydrochloride Injection, Solution
Product Images NDC 55150-160

7 FDA label images from Eugia Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 55150-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1% 20 mg/2 mL (10 mg/mL))

Package Label-principal Display Panel (1% 20 mg/2 mL (10 mg/mL))
Label for Lidocaine Hydrochloride Injection, USP, 1% (20 mg/2 mL, 10 mg/mL) solution in 2 mL vial. It is indicated for infiltration and nerve block including caudal and epidural use. The product is preservative-free and distributed by AuroMedics Pharma LLC, made in India, with NDC 55150-158-72.*
FDA Label Image

Package Label-principal Display Panel (1% 20 mg/2 mL (10 mg/mL))

Package Label-principal Display Panel (1% 20 mg/2 mL (10 mg/mL))
Packaging label for Lidocaine HCl Injection, USP 1% (20 mg/2 mL, 10 mg/mL) preservative-free solution. The label states it is for infiltration and nerve block including caudal and epidural use. The product is distributed by Auromedics Pharma LLC and contains 10 ampules of 2 mL each. NDC: 55150-158-72.*
FDA Label Image

Package Label-principal Display Panel (1% 50 mg/5 mL (10 mg/mL))

Package Label-principal Display Panel (1% 50 mg/5 mL (10 mg/mL))
Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) in 5 mL solution. Indicated for infiltration and nerve block including caudal and epidural use. The product is preservative-free, distributed by AuroMedics Pharma LLC, made in India, with NDC 55150-159-74.*
FDA Label Image

Package Label-principal Display Panel (1% 50 mg/5 mL (10 mg/mL))

Package Label-principal Display Panel (1% 50 mg/5 mL (10 mg/mL))
Box packaging label for Lidocaine HCl Injection, USP 1% (50 mg/5 mL, equivalent to 10 mg/mL) solution. This preservative-free product is indicated for infiltration and nerve block, including caudal and epidural use. The box contains 10 ampules of 5 mL each and is labeled by Auromedics Pharma LLC.*
FDA Label Image

Package Label-principal Display Panel (2% 40 mg/2 mL (20 mg/mL))

Package Label-principal Display Panel (2% 40 mg/2 mL (20 mg/mL))
Label for Lidocaine Hydrochloride Injection, USP 2% solution, 40 mg/2 mL (20 mg/mL) in a 2 mL dose. Intended for infiltration and nerve block including caudal and epidural use. The label shows it is preservative-free, distributed by AuroMedics Pharma LLC, made in India, with NDC 55150-160-72.*
FDA Label Image

Package Label-principal Display Panel (2% 40 mg/2 mL (20 mg/mL))

Package Label-principal Display Panel (2% 40 mg/2 mL (20 mg/mL))
Packaging label for Lidocaine HCl Injection, USP 2% (40 mg/2 mL or 20 mg/mL) by Auromedics. The label states the product is preservative-free, for infiltration and nerve block including caudal and epidural use, and contains 10 x 2 mL ampules. It includes the NDC 55150-160-72 and is marked Rx only.*
FDA Label Image

Lidocaine Chemical Structure (Lidocaine Str)

Lidocaine Chemical Structure (Lidocaine Str)
Chemical structure of Lidocaine Hydrochloride showing the arrangement of its molecular components including aromatic ring, amide group, and diethylamino group associated with hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.